Intellectual Property Counseling and Prosecution

Intellectual Property Counseling and Prosecution

Providing comprehensive solutions for the acquisition, enforcement and protection of IP.

Key Contacts

Meet Our Team

Areas of Focus

Expand All Collapse All

PTAB/USPTO Updates

Summaries of, and links to: decisions, legislation, and operational and personnel developments concerning the PTAB and the broader USPTO.

Federal Circuit Patent Watch

A collection of our biweekly summaries of and links to recent precedential opinions by the United States Court of Appeals for the Federal Circuit.

Experience

  • For Unified Patents, achieved a victory against American Vehicular Sciences when the Patent Trial and Appeal Board (PTAB) invalidated all challenged claims of US Patent No. 9,043,093. The ’093 patent was asserted against Honda, Nissan, Hyundai and Toyota.
  • For a major financial institution, achieved a series of victories against Intellectual Ventures, which filed suit alleging infringement of patents related to online banking. The case ended following four successful covered business method proceedings before the US Patent and Trademark Office (USPTO) in which the PTAB invalidated 83 of IV’s claims across the four patents as directed toward unpatentable abstract ideas.
  • For a technology company, provided representation in an international copyright infringement and trade secret misappropriation dispute in the United States and in parallel declaratory proceedings in the United Kingdom.
  • Numerous global companies, including a consumer electronics company, a sportswear and athletic goods company, and a car manufacturer, have relied on our representation in various trademark and trade dress matters.
  • Our copyright experience includes securing a major victory for Google in the Second Circuit in a copyright dispute with the Authors Guild over Google Books, representing an American toy and board game company against allegations of copyright infringement, and representing several major television networks in a copyright case.
  • For NitroMed, filed and obtained patents covering methods of treatment using the company’s commercial drug product, BiDil—which is targeted to the treatment of heart failure in black patients—and worked with the company to implement strategies for product life cycle management.
  • For Wyeth and its licensee XCyte, prosecuted a large and complex family of US and foreign patents concerning an anti-cancer immunotherapy.
  • Represented Columbia University in the negotiation of several intellectual property licenses, and in patent prosecution relating to diverse fields such as software applications, integrated circuits, life sciences, chemistry and physical sciences.
  • Working closely with corporate colleagues, counseled clients in transactions that include:

    • WebMD’s $160 million acquisition of VIPS
    • Idenix Pharmaceuticals’s $156.8 million IPO and private placement to Novartis
    • NitroMed’s $61.34 million IPO
    • A $49.4 million follow-on offering for Lexicon Genetics
    • A $69.7 million follow-on offering for EPIX Medical
    • Predix Pharmaceuticals’s merger with Physiome Sciences
  • A number of clients have relied on us to analyze their patent portfolios vis-a-vis their field of interest and the effect of targeted competitors’ portfolios on their business, and to complete freedom to operate analyses concerning a variety of products and technologies.

Recognition

  • Award Text

    Law Firm of the Year in Patent Law

    U.S. News - Best Lawyers® Best Law Firms List

    2021, 2022

  • Award Text

    Best Law Firms–Band One: Intellectual Property

    Chambers USA

    Since 2011

  • Award Text

    Intellectual Property Practice Group of the Year

    Law360

    2024, 2025

  • Chambers USA Guide – Ranked nationally in band one (2011–2024); noted as “outstanding at all levels, combining first-rate technical and legal acumen and great trial skills.” Consistently recognized in the national International Trade: IP (section 337) category (2013–2024) and in regional IP tables for Massachusetts (2003–2024), California (2012–2024), Colorado (2016–2024), New York (2012–2024) and Washington DC (2012–2024).

Insights & News

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.